Cantor Fitzgerald Negative on Ligand Pharma (LGND) Reaction Post-Earnings
Tweet Send to a Friend
Cantor Fitzgerald maintained a Hold rating on Ligand Pharma (NASDAQ: LGND) with a price target of $44.00. Analyst Irina Rivkind ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
